The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
methyl 8-ethynyl-6-(pyridin-2-yl)-4H-benzo[f]imidazo[1,5-a][1,4]diazepine-3-carboxylate ID: ALA4537371
PubChem CID: 88286432
Max Phase: Preclinical
Molecular Formula: C20H14N4O2
Molecular Weight: 342.36
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: C#Cc1ccc2c(c1)C(c1ccccn1)=NCc1c(C(=O)OC)ncn1-2
Standard InChI: InChI=1S/C20H14N4O2/c1-3-13-7-8-16-14(10-13)18(15-6-4-5-9-21-15)22-11-17-19(20(25)26-2)23-12-24(16)17/h1,4-10,12H,11H2,2H3
Standard InChI Key: LWYYAGMSQFPJGP-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 29 0 0 0 0 0 0 0 0999 V2000
8.9093 -9.4389 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9081 -10.2585 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6162 -10.6674 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6144 -9.0301 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3223 -10.2576 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3230 -9.4353 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9704 -10.7729 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7767 -10.5866 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.1315 -9.8395 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9664 -8.9139 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.7743 -9.0959 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1972 -8.3838 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6505 -7.7616 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.8900 -8.0892 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7906 -11.5666 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0088 -11.8082 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8285 -12.6044 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4290 -13.1599 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2127 -12.9136 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3893 -12.1179 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.0132 -8.3824 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4230 -9.0894 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.4205 -7.6740 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.2377 -7.6726 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2043 -10.6663 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4963 -11.0743 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 5 2 0
6 4 2 0
4 1 1 0
5 6 1 0
6 10 1 0
5 7 1 0
7 8 2 0
11 9 1 0
8 9 1 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 10 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 15 1 0
7 15 1 0
12 21 1 0
21 22 2 0
21 23 1 0
23 24 1 0
25 26 3 0
2 25 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 342.36Molecular Weight (Monoisotopic): 342.1117AlogP: 2.39#Rotatable Bonds: 2Polar Surface Area: 69.37Molecular Species: NEUTRALHBA: 6HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 3.05CX LogP: 2.61CX LogD: 2.61Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.53Np Likeness Score: -0.77
References 1. Maramai S, Benchekroun M, Ward SE, Atack JR.. (2020) Subtype Selective γ-Aminobutyric Acid Type A Receptor (GABAA R) Modulators Acting at the Benzodiazepine Binding Site: An Update., 63 (7): [PMID:31738537 ] [10.1021/acs.jmedchem.9b01312 ]